Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.